• Filter By:
• Specialty
• Source
• Condition
• Cancer
• Infectious Disease
• Drug
• Training
• Management
• Procedure
• Therapy
• Vaccine
• Nutrition
• Country

Current and emerging treatment modalities for bacterial rhinosinusitis in adults: A comprehensive review
Expert Opin Pharmacother. 2022 Nov 14. doi: 10.1080/14656566.2022.2147825. Online ahead of print.ABSTRACTINTRODUCTION: Rhinosinusitis (RS) is defined as acute when it lasts up to 4 weeks and chronic when it lasts at least 12 weeks. Most acute forms begin with a viral upper respiratory infection that spreads into the paranasal sinuses and is followed by bacterial infection. It is uncertain how bacteria affect chronic rhinosinusitis (CRS).AREA COVERED: : We review the current treatment of bacterial rhinosinusitis in adults, referring mainly to the two key documents published by the European Position Paper on Rhinosinusitis a...
Source: Expert Opinion on Pharmacotherapy - November 14, 2022 Category: Drugs & Pharmacology Authors: Maria Gabriella Matera Barbara Rinaldi Vito de Novellis Paola Rogliani Mario Cazzola Source Type: research

Odontogenic and rhinogenic chronic sinusitis: a modern microbiological comparison
ConclusionGiven the extent of microbiological contamination within the maxillary sinus of SCDDT patients, these infections should be regarded as a different class of conditions from rhinogenic sinusitis. Our findings support the need for different approaches in the treatment of SCDDT patients.
Source: International Forum of Allergy and Rhinology - September 8, 2015 Category: Allergy & Immunology Authors: Alberto Maria Saibene, Christian Vassena, Carlotta Pipolo, Mariele Trimboli, Elena Vecchi, Giovanni Felisati, Lorenzo Drago Tags: ORIGINAL ARTICLE Source Type: research

Clinical Practice Guideline (Update): Adult Sinusitis
Objective This update of a 2007 guideline from the American Academy of Otolaryngology—Head and Neck Surgery Foundation provides evidence-based recommendations to manage adult rhinosinusitis, defined as symptomatic inflammation of the paranasal sinuses and nasal cavity. Changes from the prior guideline include a consumer added to the update group, evidence from 42 new systematic reviews, enhanced information on patient education and counseling, a new algorithm to clarify action statement relationships, expanded opportunities for watchful waiting (without antibiotic therapy) as initial therapy of acute bacterial rhinos...
Source: Otolaryngology - Head and Neck Surgery - April 1, 2015 Category: ENT & OMF Authors: Rosenfeld, R. M., Piccirillo, J. F., Chandrasekhar, S. S., Brook, I., Ashok Kumar, K., Kramper, M., Orlandi, R. R., Palmer, J. N., Patel, Z. M., Peters, A., Walsh, S. A., Corrigan, M. D. Tags: Guideline Source Type: research

Canadian guidelines for chronic rhinosinusitis: Clinical summary.
CONCLUSION: The Canadian guidelines provide diagnosis and treatment approaches based on the current understanding of the disease and available evidence. Additionally, the guidelines provide the expert opinion of a diverse group of practice and academic experts to help guide clinicians where evidence is sparse. PMID: 24336538 [PubMed - in process]
Source: Canadian Family Physician Medecin de Famille Canadien - December 1, 2013 Category: Primary Care Authors: Kaplan A Tags: Can Fam Physician Source Type: research